NBEAL1

gene
On this page

Also known as MGC164581

Summary

NBEAL1 (neurobeachin like 1, HGNC:20681) is a protein-coding gene on chromosome 2q33.2, encoding Neurobeachin-like protein 1 (Q6ZS30).

Predicted to enable protein kinase binding activity. Predicted to be involved in protein localization. Predicted to be active in cytosol and membrane.

Source: NCBI Gene 65065 — RefSeq curated summary.

At a glance

  • GWAS associations: 32
  • Clinical variants (ClinVar): 406 total
  • MANE Select transcript: NM_001378026

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20681
Approved symbolNBEAL1
Nameneurobeachin like 1
Location2q33.2
Locus typegene with protein product
StatusApproved
AliasesMGC164581
Ensembl geneENSG00000144426
Ensembl biotypeprotein_coding
OMIM609816
Entrez65065

Gene structure

Transcript identifiers

Ensembl transcripts: 24 — 8 protein_coding, 8 retained_intron, 4 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay

ENST00000414576, ENST00000434469, ENST00000449802, ENST00000460355, ENST00000460416, ENST00000463830, ENST00000478884, ENST00000483147, ENST00000492870, ENST00000497505, ENST00000681967, ENST00000682077, ENST00000682108, ENST00000682333, ENST00000682630, ENST00000682787, ENST00000683001, ENST00000683091, ENST00000683338, ENST00000683650, ENST00000683927, ENST00000683969, ENST00000684091, ENST00000684709

RefSeq mRNA: 2 — MANE Select: NM_001378026 NM_001114132, NM_001378026

CCDS: CCDS46495, CCDS92930

Canonical transcript exons

ENST00000683969 — 56 exons

ExonStartEnd
ENSE00001333887203190292203190389
ENSE00001333892203183279203183388
ENSE00001333895203180382203180512
ENSE00001333898203175147203175287
ENSE00001333904203171928203172023
ENSE00001333910203167227203167360
ENSE00001333914203166149203166297
ENSE00001333916203151465203151589
ENSE00001333920203148991203149148
ENSE00001333921203145011203145160
ENSE00001333924203144600203144905
ENSE00001333926203138162203138315
ENSE00001333928203136599203136774
ENSE00001371491203157699203157825
ENSE00001384936203138620203138748
ENSE00001463745203197302203197391
ENSE00001463746203193795203193911
ENSE00001833013203097547203097633
ENSE00002206568203169747203169851
ENSE00002207261203122254203122343
ENSE00002208676203135677203136252
ENSE00002213757203099629203099712
ENSE00002220041203172729203172853
ENSE00002233100203130318203130476
ENSE00002234428203126824203126926
ENSE00002235744203202687203202781
ENSE00002237033203110150203110282
ENSE00002238831203131973203132132
ENSE00002241658203107608203108188
ENSE00002251991203213518203213653
ENSE00002252461203125352203125520
ENSE00002257897203111979203112098
ENSE00002283824203210958203211106
ENSE00002285606203115985203116070
ENSE00002291371203113015203113318
ENSE00002295183203126557203126716
ENSE00002301628203127781203127937
ENSE00002301936203107420203107518
ENSE00002303782203208637203208753
ENSE00002307696203199338203199447
ENSE00002316189203125960203126093
ENSE00002318888203201543203201715
ENSE00002319087203133058203133146
ENSE00002320798203209161203209322
ENSE00003467861203049814203049975
ENSE00003479507203016156203016435
ENSE00003494024203068393203068475
ENSE00003515927203083219203083525
ENSE00003555821203056427203056508
ENSE00003578053203041765203041856
ENSE00003580418203084463203084569
ENSE00003582717203077752203077837
ENSE00003596600203057326203057453
ENSE00003654468203188472203188589
ENSE00003921189203217253203225194
ENSE00003921521203014875203014982

Expression profiles

Bgee: expression breadth ubiquitous, 238 present calls, max score 93.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9706 / max 236.3705, expressed in 1797 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
2474011.62131787
247412.55011285
247390.8334284
247380.4886173
2025380.283480
247420.193858

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039793.78gold quality
calcaneal tendonUBERON:000370193.17gold quality
cauda epididymisUBERON:000436091.49gold quality
adrenal tissueUBERON:001830391.36gold quality
jejunal mucosaUBERON:000039991.28gold quality
pylorusUBERON:000116690.42gold quality
bone marrow cellCL:000209290.13gold quality
caput epididymisUBERON:000435889.88gold quality
corpus epididymisUBERON:000435989.71gold quality
saphenous veinUBERON:000731889.16gold quality
cardia of stomachUBERON:000116288.69gold quality
mucosa of paranasal sinusUBERON:000503088.18gold quality
pericardiumUBERON:000240787.20gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.00gold quality
tendonUBERON:000004386.92gold quality
renal medullaUBERON:000036286.02gold quality
mucosa of sigmoid colonUBERON:000499385.86gold quality
adult organismUBERON:000702385.70gold quality
pigmented layer of retinaUBERON:000178285.43gold quality
layer of synovial tissueUBERON:000761684.11gold quality
nippleUBERON:000203084.06gold quality
ganglionic eminenceUBERON:000402383.76gold quality
colonic mucosaUBERON:000031783.56gold quality
jejunumUBERON:000211583.53gold quality
cortical plateUBERON:000534382.63gold quality
tracheaUBERON:000312682.60gold quality
mucosa of transverse colonUBERON:000499182.38gold quality
oral cavityUBERON:000016782.19gold quality
sural nerveUBERON:001548882.19gold quality
corpus callosumUBERON:000233682.02gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-CURD-119yes13.61
E-HCAD-35yes8.15
E-CURD-135no1101.71
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

45 targeting NBEAL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-806899.9873.852376
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-545-3P99.9570.742783
HSA-MIR-335-3P99.9373.364958
HSA-MIR-806399.9169.763146
HSA-MIR-368699.9070.532432
HSA-MIR-95-5P99.8972.173973
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-808099.8267.521342
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-4645-3P99.7669.33993
HSA-MIR-6505-5P99.7369.251595
HSA-MIR-545-5P99.6670.182308
HSA-MIR-58799.6470.862611
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-360999.5269.892587
HSA-MIR-548AH-5P99.5269.732626
HSA-MIR-330-3P99.4169.952521
HSA-MIR-372-5P99.4169.112299
HSA-MIR-130A-5P99.3370.262623
HSA-MIR-3678-3P99.3167.101432
HSA-MIR-16-2-3P99.2970.601954
HSA-MIR-195-3P99.2970.611954

Literature-anchored findings (GeneRIF, showing 1)

  • isolation of human neurobeachin-like 1 (NBEAL1); highly expressed in the brain, kidney, prostate, and testis, and in biopsies of different grade glioma [NBEAL1] (PMID:15193433)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerionbeal1ENSDARG00000099547
mus_musculusNbeal1ENSMUSG00000073664
rattus_norvegicusNbeal1ENSRNOG00000021525
caenorhabditis_elegansWBGENE00004760
caenorhabditis_elegansWBGENE00007752

Paralogs (7): NSMAF (ENSG00000035681), WDFY4 (ENSG00000128815), LYST (ENSG00000143669), NBEAL2 (ENSG00000160796), WDFY3 (ENSG00000163625), NBEA (ENSG00000172915), LRBA (ENSG00000198589)

Protein

Protein identifiers

Neurobeachin-like protein 1Q6ZS30 (reviewed: Q6ZS30)

Alternative names: Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein

All UniProt accessions (12): Q6ZS30, A0A804HHU0, A0A804HI87, A0A804HIR8, A0A804HJ72, A0A804HJM0, A0A804HJX4, A0A804HKB6, A0A804HKC1, A0A804HKS6, H7BZA0, H7C3C8

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Highly expressed in brain, kidney, prostate and testis. Weakly expressed in ovary, small intestine, colon and peripheral blood leukocytes. May be correlative to several tumors, such as ovary serous adenocarcinoma and metastasis mammary gland carcinoma breast.

Similarity. Belongs to the WD repeat neurobeachin family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZS30-22yes
Q6ZS30-11

RefSeq proteins (2): NP_001107604, NP_001364955* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000409BEACH_domDomain
IPR001680WD40_rptRepeat
IPR011993PH-like_dom_sfHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR023362PH-BEACH_domDomain
IPR031570NBEA/BDCP_DUF4704Domain
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR036372BEACH_dom_sfHomologous_superfamily
IPR046851NBCH_WD40Domain
IPR050865BEACH_DomainFamily

Pfam: PF02138, PF14844, PF15787, PF16057, PF20426

UniProt features (14 total): region of interest 3, domain 2, splice variant 2, sequence conflict 2, repeat 2, compositionally biased region 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZS30-F175.200.13

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 99 (showing top): GCANCTGNY_MYOD_Q6, MILI_PSEUDOPODIA_CHEMOTAXIS_UP, CUI_TCF21_TARGETS_2_DN, AACTGGA_MIR145, THUM_SYSTOLIC_HEART_FAILURE_DN, COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN, JOHNSTONE_PARVB_TARGETS_3_DN, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, MYC_UP.V1_DN, SRC_UP.V1_DN, STK33_SKM_UP, STK33_UP, GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN

GO Biological Process (1): intracellular protein localization (GO:0008104)

GO Molecular Function (2): protein kinase binding (GO:0019901), protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
macromolecule localization1
kinase binding1
binding1
cytoplasm1

Protein interactions and networks

STRING

580 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NBEAL1ICA1LQ8NDH6693
NBEAL1FAM117BQ6P1L5652
NBEAL1WDR12Q9GZL7518
NBEAL1ZBTB44Q8NCP5472
NBEAL1CARFQ8N187456
NBEAL1A0A087WT04A0A087WT04448
NBEAL1C1QL1O75973447
NBEAL1SERTAD4Q9NUC0446
NBEAL1TRIM65Q6PJ69437
NBEAL1SLC25A44Q96H78430
NBEAL1MRPL38Q96DV4423
NBEAL1SACSQ9NZJ4422
NBEAL1TRIM47Q96LD4419
NBEAL1C16orf95Q9H693418
NBEAL1SH3PXD2AQ5TCZ1405

IntAct

30 interactions, top by confidence:

ABTypeScore
SDC2PDPK1psi-mi:“MI:0914”(association)0.640
ANKRD22ESYT2psi-mi:“MI:0914”(association)0.530
ILVBLSLC33A1psi-mi:“MI:0914”(association)0.530
Nek9EML1psi-mi:“MI:0914”(association)0.350
AP1S2SLC43A3psi-mi:“MI:0914”(association)0.350
RGMABDP1psi-mi:“MI:0914”(association)0.350
HNRNPA1MATR3psi-mi:“MI:0914”(association)0.350
HNRNPUpsi-mi:“MI:0914”(association)0.350
Klc2KLC1psi-mi:“MI:0914”(association)0.350
Smc1aPDS5Bpsi-mi:“MI:0914”(association)0.350
HIF1APIAS1psi-mi:“MI:0914”(association)0.350
KIF1CHSPA8psi-mi:“MI:0914”(association)0.350
Spire2KLF4psi-mi:“MI:0914”(association)0.350
CHMP4Bpsi-mi:“MI:0914”(association)0.350
CNTROBCENPXpsi-mi:“MI:0914”(association)0.350
SDC2METTL8psi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
VPS35ILVBLpsi-mi:“MI:0914”(association)0.350
NPTNRTL8Cpsi-mi:“MI:0914”(association)0.350
KCNE3TMEM131Lpsi-mi:“MI:0914”(association)0.350
CD40IPO5psi-mi:“MI:0914”(association)0.350
DHCR24PDE2Apsi-mi:“MI:0914”(association)0.350
NPTNRIMOC1psi-mi:“MI:0914”(association)0.350
S1PR3STXBP3psi-mi:“MI:0914”(association)0.350
VSIG1RIMOC1psi-mi:“MI:0914”(association)0.350
MFSD14AFAM171A2psi-mi:“MI:0914”(association)0.350
NBEAL1hflKpsi-mi:“MI:0915”(physical association)0.000
NBEAL1psi-mi:“MI:0915”(physical association)0.000
NBEAL1cobBpsi-mi:“MI:0915”(physical association)0.000

BioGRID (35): NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-RNA), NBEAL1 (Proximity Label-MS)

ESM2 similar proteins: A0JM23, A0M8T3, A1X154, A6H7D1, A7MBF6, A8Y5U1, B1WC10, E9Q9R9, F1M649, F1MHT9, O00750, O88480, O95876, P0CI65, P50851, Q008S8, Q00PJ3, Q07E17, Q07E30, Q07E43, Q09YN0, Q108U1, Q15052, Q2IBF5, Q2IBG0, Q2QLA4, Q2QLB5, Q32NR4, Q32NR9, Q3UP24, Q3V129, Q4V7F0, Q5XXR3, Q5ZLR6, Q692V3, Q6AZT7, Q6P2S7, Q6P3V7, Q6PIY5, Q6ZS30

Diamond homologs: A1C7E4, A5D7H2, D5GBI7, G4MQX3, O43815, O54927, O55106, P47025, P49026, P58404, P58405, P70483, P93340, P97499, Q00659, Q05040, Q13033, Q499N3, Q4VBE8, Q54J37, Q54TD8, Q5U2W5, Q68FJ6, Q6ZS30, Q7T2F6, Q8C4J7, Q99973, Q9C270, Q9ERG2, Q9NRL3, Q9Y6I7, A8XSV3, D4A929, E7FAW3, E9Q2M9, F4HZB2, F4IG73, F4JD14, F4JHT3, O35242

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

406 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance336
Likely benign19
Benign8

Top pathogenic / likely-pathogenic (0)

SpliceAI

9340 predictions. Top by Δscore:

VariantEffectΔscore
2:203014983:G:GGdonor_gain1.0000
2:203016151:CACA:Cacceptor_loss1.0000
2:203016153:CA:Cacceptor_loss1.0000
2:203016154:A:Cacceptor_loss1.0000
2:203016155:GATTT:Gacceptor_gain1.0000
2:203041759:TTTCA:Tacceptor_loss1.0000
2:203041761:TCA:Tacceptor_loss1.0000
2:203041762:CAG:Cacceptor_loss1.0000
2:203041763:A:AGacceptor_gain1.0000
2:203041763:AG:Aacceptor_loss1.0000
2:203041764:G:Aacceptor_loss1.0000
2:203041764:G:GGacceptor_gain1.0000
2:203041764:GAA:Gacceptor_gain1.0000
2:203041764:GAAA:Gacceptor_gain1.0000
2:203041852:ACCAG:Adonor_loss1.0000
2:203041853:CCAG:Cdonor_loss1.0000
2:203041854:CAGGT:Cdonor_loss1.0000
2:203041855:AGGT:Adonor_loss1.0000
2:203041856:GGTA:Gdonor_loss1.0000
2:203041857:G:Adonor_loss1.0000
2:203041858:T:Adonor_loss1.0000
2:203049951:TC:Tdonor_gain1.0000
2:203056505:GCAA:Gdonor_gain1.0000
2:203056509:G:GGdonor_gain1.0000
2:203057324:A:AGacceptor_gain1.0000
2:203057325:G:GAacceptor_gain1.0000
2:203057325:GTT:Gacceptor_gain1.0000
2:203057325:GTTA:Gacceptor_gain1.0000
2:203057325:GTTAA:Gacceptor_gain1.0000
2:203057452:GG:Gdonor_gain1.0000

AlphaMissense

18009 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:203171931:T:AW2007R1.000
2:203171931:T:CW2007R1.000
2:203016415:T:AW11R0.999
2:203016415:T:CW11R0.999
2:203041789:T:AW26R0.999
2:203041789:T:CW26R0.999
2:203057434:T:AW166R0.999
2:203057434:T:CW166R0.999
2:203108085:T:AW587R0.999
2:203108085:T:CW587R0.999
2:203108174:G:CR616S0.999
2:203108174:G:TR616S0.999
2:203110181:G:CA632P0.999
2:203113222:T:AW775R0.999
2:203113222:T:CW775R0.999
2:203171933:G:CW2007C0.999
2:203171933:G:TW2007C0.999
2:203171965:T:CL2018P0.999
2:203171992:G:CR2027P0.999
2:203172735:T:AW2040R0.999
2:203172735:T:CW2040R0.999
2:203183341:T:AW2191R0.999
2:203183341:T:CW2191R0.999
2:203188505:T:AW2218R0.999
2:203188505:T:CW2218R0.999
2:203199377:T:AW2361R0.999
2:203199377:T:CW2361R0.999
2:203077809:T:CL219P0.998
2:203077815:G:AG221E0.998
2:203084505:T:CL345P0.998

dbSNP variants (sampled 300 via entrez): RS1000003364 (2:203218113 C>A,T), RS1000015097 (2:203169953 C>T), RS1000029369 (2:203191129 G>A), RS1000057771 (2:203090546 A>G), RS1000061903 (2:203043949 C>G,T), RS1000062484 (2:203122158 A>G), RS1000081882 (2:203116440 A>T), RS1000119670 (2:203203180 T>C), RS1000143143 (2:203069978 A>G), RS1000172274 (2:203203480 CTG>C), RS1000175928 (2:203163296 G>T), RS1000186357 (2:203083966 T>C), RS1000200635 (2:203014428 T>G), RS1000229634 (2:203145533 C>T), RS1000270192 (2:203155697 C>T)

Disease associations

OMIM: gene MIM:609816 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

32 associations (top):

StudyTraitp-value
GCST001762_197Obesity-related traits3.000000e-06
GCST001762_242Obesity-related traits4.000000e-07
GCST001762_762Obesity-related traits2.000000e-07
GCST001762_782Obesity-related traits2.000000e-07
GCST003013_22White matter hyperintensity burden5.000000e-08
GCST003013_8White matter hyperintensity burden6.000000e-08
GCST005194_24Coronary artery disease2.000000e-32
GCST005195_132Coronary artery disease1.000000e-32
GCST005196_213Coronary artery disease2.000000e-32
GCST007269_79Pulse pressure4.000000e-13
GCST008876_38Non-lobar intracerebral hemorrhage (MTAG)2.000000e-07
GCST008876_39Non-lobar intracerebral hemorrhage (MTAG)2.000000e-07
GCST010101_5White matter hyperintensities4.000000e-13
GCST010102_1White matter integrity (fractional anisotropy)7.000000e-08
GCST010102_2White matter integrity (fractional anisotropy)6.000000e-09
GCST010396_12Gut microbiota (bacterial taxa, hurdle binary method)9.000000e-06
GCST010698_18Subcortical volume (min-P)1.000000e-08
GCST010699_69Brain morphology (min-P)9.000000e-20
GCST010700_6Cortical thickness (MOSTest)2.000000e-14
GCST010701_36Cortical surface area (MOSTest)2.000000e-24
GCST010702_146Subcortical volume (MOSTest)2.000000e-13
GCST010703_42Brain morphology (MOSTest)1.000000e-08
GCST010726_17Periventricular white matter hyperintensities1.000000e-09
GCST011946_34White matter hyperintensity volume7.000000e-13
GCST011949_4White matter hyperintensity volume (adjusted for hypertension)1.000000e-12
GCST011952_7White matter hyperintensity volume x hypertension interaction (2df)5.000000e-12
GCST012580_2White matter hyperintensities6.000000e-09
GCST90000582_10Spontaneous coronary artery dissection2.000000e-06
GCST90000582_11Spontaneous coronary artery dissection9.000000e-06
GCST90002397_458Mean spheric corpuscular volume1.000000e-12

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0004338body weight
EFO:0005106body composition measurement
EFO:0005665white matter hyperintensity measurement
EFO:0005763pulse pressure measurement
EFO:0010178non-lobar intracerebral hemorrhage
EFO:0004641white matter integrity
EFO:0007874gut microbiome measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, affects expression3
sodium arseniteaffects cotreatment, decreases expression, increases abundance, increases expression2
Arsenicaffects cotreatment, decreases expression, increases abundance, increases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamideincreases expression1
FR900359affects phosphorylation1
triphenyl phosphateaffects expression1
arsenitedecreases reaction, affects binding1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
potassium chromate(VI)affects cotreatment, decreases expression1
2,3-bis(3’-hydroxybenzyl)butyrolactoneaffects cotreatment, decreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
jinfukangaffects cotreatment, decreases expression1
Resveratrolaffects cotreatment, increases expression1
Air Pollutantsdecreases expression1
Caffeineaffects phosphorylation1
Cisplatinaffects cotreatment, decreases expression1
Coumestrolaffects cotreatment, decreases expression1
Dimethyl Sulfoxideincreases expression1
Doxorubicinincreases expression1
Hydralazineaffects cotreatment, increases expression1
Hydrogen Peroxideaffects cotreatment, decreases expression1
Manganesedecreases expression, increases abundance, affects cotreatment1
Methyl Methanesulfonateincreases expression1
Plant Extractsaffects cotreatment, increases expression1
Dronabinolincreases expression1
Theophyllineaffects cotreatment, decreases expression1
Cyclosporineincreases expression1
Aflatoxin B1decreases expression1
Antirheumatic Agentsincreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_TA03HAP1 NBEAL1 (-)Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder, stroke disorder